Items Tagged ‘Xgeva’

February 9th, 2012

FDA panel votes against Xgeva for prostate cancer

By

panel of cancer experts voted against a new use for Amgen’s Xgeva in prostate cancer on Wednesday, saying the drug’s ability to slow the spread of the disease did not translate into meaningful benefits for patients.The Food and Drug Administration’s cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its […]

View full entry

Tags: amgen, cancer drug panel, Dr. Ronald Richardson, FDA, Food and Drug Administration, prostate cancer, Xgeva


Contact Us · Privacy Policy